ksr-2 Antibody

What is KSR-2 and why is it important in cellular signaling research?

KSR2 functions as a molecular scaffold that potently regulates the MAP kinases ERK1/2 and affects multiple cell fates. Beyond its scaffolding function, KSR2 interacts with and modulates the activity of AMPK, a critical regulator of cellular energy homeostasis. This dual functionality makes KSR2 an important research target for understanding both MAPK signaling and metabolic regulation . When using KSR-2 antibodies, researchers should consider these multiple functions and design experiments that can differentiate between KSR2's scaffolding effects and its direct interaction with metabolic regulators.

What are the most common applications for KSR-2 antibodies in research settings?

KSR-2 antibodies are primarily used in immunoprecipitation experiments to detect KSR2-ERK and KSR2-MEK associations, Western blotting to assess KSR2 expression levels, and cell-based ELISAs to examine KSR2 protein expression profiles in different cell types . These antibodies enable researchers to investigate how KSR2 expression patterns change in response to various treatments, inhibitors (including siRNA or chemicals), or activators. When designing experiments, researchers should select antibody applications that align with their specific research questions, whether examining protein-protein interactions, expression levels, or localization patterns.

How do I determine the appropriate KSR-2 antibody concentration for Western blotting?

For optimal Western blotting results with KSR-2 antibodies, researchers should perform a titration experiment using a range of antibody dilutions (typically 1:500 to 1:5000) against a standardized amount of protein lysate containing KSR2. When analyzing tissues with variable KSR2 expression, note that KSR2 shows higher expression in brain tissue compared to adipose tissue, which should be considered when determining optimal antibody concentrations . Always include appropriate positive controls (such as tissue or cells known to express KSR2) and negative controls (such as KSR2-knockout samples if available) to validate antibody specificity.

How can I distinguish between KSR1 and KSR2 in my experimental system?

Despite structural similarities, KSR1 and KSR2 have dramatically different physiological functions that must be carefully distinguished in experimental settings . When using antibodies, verify their specificity by:

• Using KSR1-/- and KSR2-/- cell lines or tissues as controls

• Performing peptide competition assays with specific blocking peptides

• Validating results with multiple antibodies targeting different epitopes

• Complementing protein detection with mRNA analysis using isoform-specific primers

What considerations should researchers make when analyzing KSR2-AMPK interactions using antibody-based techniques?

When investigating KSR2-AMPK interactions, researchers should recognize that these interactions may be dynamic and condition-dependent. Co-immunoprecipitation experiments should be performed under specific conditions that preserve these interactions . Consider:

• Using mild lysis conditions (e.g., buffers containing 1% Brij 98 rather than stronger detergents)

• Including appropriate phosphatase inhibitors (sodium orthovanadate, sodium fluoride, β-glycerophosphate)

• Testing different stimulation conditions (serum starvation followed by growth factor stimulation)

• Designing reciprocal immunoprecipitations (IP with anti-KSR2 followed by AMPK detection and vice versa)

As demonstrated in brain lysate experiments, endogenous KSR2-AMPK interactions can be detected by immunoprecipitating with antibodies against AMPKα subunit and probing for KSR2 on western blot .

How should KSR-2 antibodies be used to evaluate the role of KSR2 in tumor cell growth?

For investigating KSR2's role in tumor cell growth, researchers should design experiments that combine antibody-based detection methods with functional assays. KSR2 has been shown to enhance proliferation rates and promote anchorage-independent growth, a hallmark of transformation . A comprehensive approach should include:

• Using KSR2 antibodies to confirm knockdown efficiency in siRNA or shRNA experiments

• Validating KSR2 expression levels in cells engineered to express varying amounts of wild-type or mutant KSR2

• Correlating KSR2 protein levels with phenotypic outcomes in proliferation and soft agar assays

• Examining downstream signaling effects by monitoring ERK activation and AMPK-dependent processes

This integrated approach allows researchers to connect KSR2 expression levels directly to functional outcomes in cancer models.

What are the recommended protocols for immunoprecipitation of KSR2 complexes?

Based on published protocols, KSR2 immunoprecipitation requires carefully optimized conditions to preserve protein-protein interactions. For KSR2-ERK association studies:

• Subject cells to serum starvation for 4 hours followed by EGF stimulation (5 minutes)

• Lyse cells in buffer containing 25 mM Tris (pH 7.4), 125 mM NaCl, 1 mM MgCl₂, and 1% Brij 98

• Include protease inhibitors (10 μg/ml aprotinin, 20 mM leupeptin, 1 mM PMSF) and phosphatase inhibitors (0.5 mM sodium orthovanadate, 10 mM sodium fluoride, 10 mM β-glycerophosphate)

• For FLAG-tagged KSR2, immunoprecipitate with anti-FLAG-conjugated agarose overnight

• Wash beads three times with lysis buffer and elute with FLAG peptide

For endogenous KSR2 complexes, use antibodies specific to KSR2 and validate results with appropriate controls to ensure specificity.

How can I optimize cell-based ELISA protocols for KSR2 detection?

Cell-based ELISA provides a high-throughput method for analyzing KSR2 expression in adherent or suspension cells. To optimize this approach:

• Ensure adequate cell density (>5000 cells per well) for reliable detection

• Implement multiple normalization methods:

  • Use anti-GAPDH antibody as an internal positive control

  • Apply Crystal Violet whole-cell staining to normalize for cell number

• Follow a standardized protocol:

  • Capture KSR2 with specific primary antibodies

  • Detect using HRP-conjugated secondary antibodies

  • Measure colorimetric reaction upon substrate addition

This approach allows for qualitative determination of KSR2 concentration and assessment of how various treatments affect KSR2 expression across different cell lines.

What controls should be included when using KSR-2 antibodies in knockout or knockdown studies?

Rigorous controls are essential when using antibodies in genetic manipulation experiments:

• Wild-type samples (positive control)

• Complete knockout samples (KSR2-/- tissues/cells) as negative controls

• Heterozygous samples (KSR2+/-) to demonstrate dose-dependent detection

• Isotype control antibodies to assess non-specific binding

• Secondary antibody-only controls

• For knockdown experiments, include scrambled/non-targeting siRNA controls

In published studies of KSR2 function, researchers verified genotypes through both genotyping and western blotting, demonstrating the absence of KSR2 protein in KSR2-/- tissues compared to wild-type samples .

How can researchers address inconsistent KSR2 detection across different tissue samples?

KSR2 expression varies significantly across tissues, with higher expression in brain and lower expression in adipose tissue . To address detection challenges:

• Adjust protein loading amounts based on expected expression levels

• Optimize extraction protocols for specific tissue types:

  • For brain tissue: use buffers containing 1% Brij 98

  • For adipose tissue: include lipid removal steps before analysis

• Consider tissue-specific post-translational modifications that might affect epitope recognition

• Use signal enhancement techniques for tissues with low expression

• Validate antibody performance in each new tissue type before conducting full experiments

Remember that despite low expression in some tissues (e.g., adipose), KSR2 can still have significant functional effects on AMPK-mediated processes .

What experimental approaches can resolve discrepancies in KSR2 antibody results across different detection methods?

When facing inconsistencies between different detection methods:

• Verify antibody specificity through multiple validation techniques:

  • Peptide competition assays

  • Testing in knockout/knockdown systems

  • Using multiple antibodies targeting different epitopes

• Consider epitope accessibility issues:

  • Native vs. denatured conditions may affect antibody binding

  • Protein complexes might mask epitopes in certain assays

• Implement orthogonal detection methods:

  • Complement protein detection with mRNA analysis

  • Use mass spectrometry to confirm antibody specificity

• Standardize sample preparation across all detection methods

This systematic approach can help identify the source of discrepancies and determine which results are most reliable.

How can researchers investigate the interaction between KSR2 mutations and AMPK signaling using antibody-based techniques?

To study how KSR2 mutations affect AMPK signaling:

• Generate cell lines expressing KSR2 variants (such as KSR2.FIFP/AAAP, KSR2.C907Y) using retroviral infection followed by flow cytometry-based isolation

• Validate expression levels of mutant proteins by Western blotting using KSR2 antibodies

• Assess AMPK activation by measuring phosphorylation of AMPK (Thr172) and its substrate acetyl-CoA carboxylase (ACC, Ser79)

• Compare AMPK responsiveness to activators like AICAR between wild-type and mutant KSR2-expressing cells

• Investigate downstream effects on processes like fatty acid oxidation and glucose uptake

This methodological approach enables researchers to dissect how specific KSR2 domains contribute to AMPK regulation and subsequent metabolic outcomes.

What are emerging applications of KSR-2 antibodies in metabolic research?

Given KSR2's established role in metabolic regulation, emerging applications include:

• Using KSR2 antibodies in tissue microarrays to correlate expression with metabolic disease states

• Applying proximity ligation assays to study KSR2-AMPK interactions in situ in various tissues

• Developing phospho-specific KSR2 antibodies to monitor its activation state

• Employing super-resolution microscopy with fluorescently labeled antibodies to track KSR2 localization during metabolic challenges

These applications will help further our understanding of how KSR2 coordinates cellular signaling networks in metabolic health and disease.

How might KSR-2 antibodies contribute to translational research in obesity and diabetes?

KSR2 knockout mice display obesity and insulin resistance despite being hypophagic and hyperactive , suggesting KSR2 as a potential therapeutic target. KSR2 antibodies can aid translational research by:

• Enabling high-throughput screens to identify compounds that modulate KSR2-AMPK interactions

• Facilitating biomarker studies to correlate KSR2 expression or phosphorylation with disease progression

• Supporting tissue-specific analyses to determine which organs rely most heavily on KSR2 for metabolic regulation

• Validating target engagement in preclinical studies of KSR2-modulating therapeutics